mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.27 |
0.4 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.16 |
0.4 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
-0.1 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |